Verona pharma to present at h.c. wainwright bioconnect virtual conference

London and raleigh, n.c., jan. 04, 2022 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that david zaccardelli, pharm. d., president and chief executive officer, will present a company overview at the h.c. wainwright bioconnect virtual conference. the presentation will be available on-demand starting at 7:00 am est / 12:00 pm gmt on monday, january 10, 2022.
VRNA Ratings Summary
VRNA Quant Ranking